Purchase Order 75N91019P00762

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $10,146.00 on July 25, 2017, for laboratory supplies with ultimate completion on August 23, 2017. Place of performance is Carlsbad, California. The order is firm fixed price with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $13,879.50 in biological kits, with an award date of June 13, 2019 and completion date of July 13, 2019. Place of performance is Carlsbad, California. The order is priced on a firm fixed price basis with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for biological kits valued at $14,923.40 on August 24, 2020, with an ultimate completion date of September 23, 2020. Place of performance is Carlsbad, California. The order carries firm fixed pricing with no set-aside designation.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $19,953.15 on July 26, 2017, for lab supplies with firm fixed pricing and no set-aside designation. Place of performance is Carlsbad, California. The order completes on August 24, 2017.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $5,611.84 on July 11, 2017, with ultimate completion on August 16, 2018. No set-aside was used. Performance occurs in Bethesda, Maryland. The order is for laboratory instrumentation, reagents, consumables, or maintenance services typical of Life Technologies' federal portfolio in life-sciences research and diagnostic infrastructure. Pricing is firm fixed price.</p>

<p>The National Cancer Institute issued a purchase order to Life Technologies Corporation for biological kits valued at $13,697.04, awarded July 9, 2019, with ultimate completion August 8, 2019. Place of performance is Carlsbad, California. The order carries firm fixed price commercial item pricing with no set-aside applied.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $14,960 on July 19, 2017, for laboratory supplies, with an ultimate completion date of August 17, 2017. The order is firm fixed price with no set-aside applied. Place of performance is Carlsbad, California. Life Technologies, operating as Thermo Fisher Scientific, manufactures laboratory instrumentation, reagents, and consumables supplied across federal research and diagnostic sectors.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for $22,130 in lab equipment on June 9, 2021, with completion by July 9, 2021. The award carries no small business set-aside. Performance is in Carlsbad, California. The order is firm fixed price and was issued to de-obligate expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) ahead of the September 30, 2026 close of the period of availability.</p>

<p>The National Cancer Institute awarded a purchase order to Life Technologies Corporation for lab equipment valued at $24,628.60 on September 22, 2020, with completion on December 22, 2020. Performance takes place in Bethesda, Maryland. The order is firm fixed price with no small business set-aside applied.</p>

The National Cancer Institute awarded a purchase order to Life Technologies Corporation valued at $14,599.10 on July 18, 2017, for laboratory supplies with an ultimate completion date of August 17, 2017. The order is firm fixed price with no set-aside applied. Place of performance is Carlsbad, California. Life Technologies, operating as Thermo Fisher Scientific, supplies laboratory instrumentation, reagents, and consumables to federal research and diagnostic programs across the life sciences...